UK markets closed
  • NIKKEI 225

    27,049.47
    +178.20 (+0.66%)
     
  • HANG SENG

    22,418.97
    +189.45 (+0.85%)
     
  • CRUDE OIL

    111.84
    +2.27 (+2.07%)
     
  • GOLD FUTURES

    1,821.40
    -3.40 (-0.19%)
     
  • DOW

    30,946.99
    -491.27 (-1.56%)
     
  • BTC-GBP

    16,705.43
    -472.67 (-2.75%)
     
  • CMC Crypto 200

    441.05
    -9.01 (-2.00%)
     
  • ^IXIC

    11,181.54
    -343.01 (-2.98%)
     
  • ^FTAS

    4,035.24
    +31.01 (+0.77%)
     

This Exciting Biotech Stock Could Be Your Next 10-Bagger

·4-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The stock performance of 23andMe (NASDAQ: ME) has plunged since it went public last June. But, in this video clip from "The Rank" on Motley Fool Live, recorded on March 28, Fool.com contributors Matt Frankel and Travis Hoium discuss a few of the biotech company's promising business plans that could pay off in a big way over the next few years.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting